title: Identification of residues critical for Ras(17N) growth-inhibitory phenotype and for Ras interaction with guanine nucleotide exchange factors.
abstract: The Ras(17N) dominant negative antagonizes endogenous Ras function by forming stable, inactive complexes with Ras guanine nucleotide exchange factors (GEFs; e.g., SOS1). We have used the growth-inhibitory phenotype of Ras(17N) to characterize two aspects of Ras interaction with GEFs. First, we used a nonprenylated version of Ras(17N), designated Ras(17N/186S), which no longer associates with the plasma membrane and lacks the growth-inhibitory phenotype, to address the importance of Ras subcellular location and posttranslational modification for its interaction with GEFs. We observed that addition of an N-terminal myristylation signal to Ras(17N/186S) restored the growth-inhibitory activity of nonprenylated Ras(17N). Thus, membrane association, rather than prenylation, is critical for Ras interaction with Ras GEFs. Second, we used a biological selection approach to identify Ras residues which are critical for Ras(17N) growth inhibition and hence for interaction with Ras GEFs. We identified mutations at residues 75, 76, and 78 that abolished the growth-inhibitory activity of Ras(17N). Since GEF interaction is dispensable for oncogenic but not normal Ras function, our demonstration that single-amino-acid substitutions at these three positions impaired the transforming activity of normal but not oncogenic Ras provides further support for the role of these residues in Ras-GEF interactions. Finally, Ras(WT) proteins with mutations at these residues were no longer activated by mammalian SOS1. Altogether, these results suggest that the Ras intracellular location and Ras residues 75 to 78 are critical for Ras-GEF interaction.
authors.affiliation: Department of Pharmacology, University of North Carolina at Chapel Hill School of Medicine 27599.
authors.forename: L A
authors.initials: LA
authors.lastname: Quilliam
authors.forename: K
authors.initials: K
authors.lastname: Kato
authors.forename: K M
authors.initials: KM
authors.lastname: Rabun
authors.forename: M M
authors.initials: MM
authors.lastname: Hisaka
authors.forename: S Y
authors.initials: SY
authors.lastname: Huff
authors.forename: S
authors.initials: S
authors.lastname: Campbell-Burk
authors.forename: C J
authors.initials: CJ
authors.lastname: Der
mesh_terms: D016475:3T3 Cells; D000595:Amino Acid Sequence; D000818:Animals; D002455:Cell Division; D015500:Chloramphenicol O-Acetyltransferase; D003545:Cysteine; D019204:GTP-Binding Proteins / Q000378:metabolism*; D015870:Gene Expression; D006801:Humans; D051379:Mice; D008969:Molecular Sequence Data; D016296:Mutagenesis; D019814:Myristic Acid; D009227:Myristic Acids / Q000494:pharmacology; D015689:Oncogene Protein p21(ras) / Q000235:genetics / Q000378:metabolism*; D010641:Phenotype; D017354:Point Mutation; D015183:Restriction Mapping; D017386:Sequence Homology, Amino Acid; D012694:Serine; D014158:Transcription, Genetic; D014162:Transfection
chemical_list: D009227:Myristic Acids; D019814:Myristic Acid; D012694:Serine; D015500:Chloramphenicol O-Acetyltransferase; D019204:GTP-Binding Proteins; D015689:Oncogene Protein p21(ras); D003545:Cysteine